A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitors
Fig 4
Comparison of simulations of the activation of FXII, PK and cleavage of HK with the experimental data from Björkqvist et al [30].
a) [DXS] = 0.1 μg/ml, b) [DXS] = 1 μg/ml.